Skip to content

Apotheek Leviora: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Leviora

BE 0434.101.427
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€30,691
2024 · €16,571+€14,121
Equity
€402,330
2024 · €401,639+€691
Cash
€84,083
2024 · €80,428+€3,656
Balance sheet total
€545,471
2024 · €577,549-€32,078

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€35,953

    down €35,953 (-9.4%), from €383,945 to €347,991

    of which Other amounts receivable: -€46,687

  • Stocks and contracts +€8,033

    up €8,033 (+8.4%), from €95,957 to €103,990

  • Tangible fixed assets -€6,838

    down €6,838 (-54.2%), from €12,607 to €5,768

Equity and liabilities
  • Trade debts -€49,972

    down €49,972 (-33.6%), from €148,722 to €98,749

  • Other debts +€14,064

    up €14,064 (+87.8%), from €16,015 to €30,080

Income statement
  • Depreciation -€10,530

    down €10,530 (-63.9%), from €16,470 to €5,939

  • Gross operating margin +€6,744

    up €6,744 (+5.6%), from €120,329 to €127,073

  • Staff costs +€2,509

    up €2,509 (+3.3%), from €75,127 to €77,636

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €16,571
Gross operating margin +€6,744
Staff costs -€2,509
Depreciation +€10,530
Other operating charges -€75
Other operating items -€899
Financial income +€40
Financial charges +€323
Taxes -€33
Result 2025 €30,691
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€32,757
Investment +€899
Financing -€30,000
Cash 2024 €80,428
Net result for the year +€30,691
Depreciation +€5,939
Stocks and contracts -€8,033
Receivables within one year +€35,953
Deferred charges and accrued income +€975
Trade debts -€49,972
Tax, wage and social debts +€3,242
Other debts +€14,064
Accrued charges and deferred income -€104
Investment in fixed assets (net) +€899
Contributions, distributions and other -€30,000
Cash 2025 €84,083
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €577,549 €545,471 -€32,078 -5.6%
Fixed assets 21/28 €12,607 €5,768 -€6,838 -54.2%
Tangible fixed assets 22/27 €12,607 €5,768 -€6,838 -54.2%
Land and buildings 22 €1,650 - -€1,650
Plant, machinery and equipment 23 €8,408 €5,768 -€2,639 -31.4%
Furniture and vehicles 24 €899 - -€899
Leasing and similar rights 25 €1,650 - -€1,650
Current assets 29/58 €564,942 €539,702 -€25,240 -4.5%
Stocks and contracts in progress 3 €95,957 €103,990 +€8,033 +8.4%
Stocks 30/36 €95,957 €103,990 +€8,033 +8.4%
Amounts receivable within one year 40/41 €383,945 €347,991 -€35,953 -9.4%
Trade receivables 40 €93,994 €104,728 +€10,734 +11.4%
Other amounts receivable 41 €289,951 €243,264 -€46,687 -16.1%
Cash at bank and in hand 54/58 €80,428 €84,083 +€3,656 +4.5%
Deferred charges and accrued income 490/1 €4,613 €3,638 -€975 -21.1%
Total equity and liabilities 10/49 €577,549 €545,471 -€32,078 -5.6%
Equity 10/15 €401,639 €402,330 +€691 +0.2%
Contributions 10/11 €31,000 €31,000 = 0.0%
Reserves 13 €368,016 €368,016 = 0.0%
Distributable reserves 133 €368,016 €368,016 = 0.0%
Profit (loss) carried forward 14 €2,623 €3,314 +€691 +26.4%
Amounts payable 17/49 €175,910 €143,141 -€32,770 -18.6%
Amounts payable within one year 42/48 €175,614 €142,949 -€32,666 -18.6%
Trade debts 44 €148,722 €98,749 -€49,972 -33.6%
Suppliers 440/4 €148,722 €98,749 -€49,972 -33.6%
Taxes, remuneration and social security 45 €10,877 €14,119 +€3,242 +29.8%
Taxes 450/3 €853 €887 +€35 +4.1%
Remuneration and social security 454/9 €10,025 €13,232 +€3,207 +32.0%
Other amounts payable 47/48 €16,015 €30,080 +€14,064 +87.8%
Accrued charges and deferred income 492/3 €296 €192 -€104 -35.1%
Remuneration, social security and pensions 62 €75,127 €77,636 +€2,509 +3.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,470 €5,939 -€10,530 -63.9%
Other operating charges 640/8 €1,061 €1,135 +€75 +7.0%
Non-recurring operating charges 66A - €899 +€899
Gross operating margin 9900 €120,329 €127,073 +€6,744 +5.6%
Operating profit (loss) 9901 €27,672 €41,463 +€13,791 +49.8%
Financial income 75/76B - €40 +€40
Recurring financial income 75 - €40 +€40
Financial charges 65/66B €10,249 €9,926 -€323 -3.2%
Recurring financial charges 65 €10,249 €9,926 -€323 -3.2%
Profit (loss) for the period before taxes 9903 €17,423 €31,577 +€14,154 +81.2%
Income taxes 67/77 €853 €886 +€33 +3.9%
Profit (loss) for the period 9904 €16,571 €30,691 +€14,121 +85.2%
Profit (loss) for the period to be appropriated 9905 €16,571 €30,691 +€14,121 +85.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.